Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2020-11, Vol.34 (11), p.e676-e679 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e679 |
|---|---|
| container_issue | 11 |
| container_start_page | e676 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 34 |
| creator | Fougerousse, A.‐C. Perrussel, M. Bécherel, P.‐A. Begon, E. Pallure, V. Zaraa, I. Chaby, G. Parier, J. Kemula, M. Mery‐Bossard, L. Poreaux, C. Taieb, C. Maccari, F. Reguiai, Z. |
| description | |
| doi_str_mv | 10.1111/jdv.16761 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7323155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2415828662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5131-1b35923f3c7c1e7a57ceb51ca4f3d53d15c586f5d8c5c2849abd32a95fac05d33</originalsourceid><addsrcrecordid>eNp1kc9O3DAQh60KVLa0h74A8hEOgYwd58-lEtotBYTEoS1Xy3EmYEjirSe71d54hD5jnwQvCwgO-GJr5tM3I_8Y-wrpIcRzdNssDyEvcvjAJpDlZSLTUm6xSVqJPKkqVe2wT0S3aZoCqPIj25FC5VkGxYQNP1c0Yu8s94HXznf-Or7HgGbscRi5G_icfHCGHPG5GV0sEm88Eh_8um0jSsjHG-TB0R33LTeccIkBeetDvy5ML6_OZv_v_0H1mW23piP88nTvst8n339NT5OLyx9n0-OLxCqQkEAtVSVkK21hAQujCou1AmuyVjZKNqCsKvNWNaVVVpRZZepGClOp1thUNVLusm8b73xR99jYuHUwnZ4H15uw0t44_bYzuBt97Ze6kEKCUlGw_yQI_s8CadS9I4tdZwb0C9Iiiz8pyjwXET3YoDZ4ooDtyxhI9TofHfPRj_lEdu_1Xi_kcyARONoAf12Hq_dN-nx2tVE-AKtbnN8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2415828662</pqid></control><display><type>article</type><title>Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fougerousse, A.‐C. ; Perrussel, M. ; Bécherel, P.‐A. ; Begon, E. ; Pallure, V. ; Zaraa, I. ; Chaby, G. ; Parier, J. ; Kemula, M. ; Mery‐Bossard, L. ; Poreaux, C. ; Taieb, C. ; Maccari, F. ; Reguiai, Z.</creator><creatorcontrib>Fougerousse, A.‐C. ; Perrussel, M. ; Bécherel, P.‐A. ; Begon, E. ; Pallure, V. ; Zaraa, I. ; Chaby, G. ; Parier, J. ; Kemula, M. ; Mery‐Bossard, L. ; Poreaux, C. ; Taieb, C. ; Maccari, F. ; Reguiai, Z. ; GEM Resopso ; the GEM Resopso</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.16761</identifier><identifier>PMID: 32564417</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Adult ; Aged ; Biological Products - therapeutic use ; Comorbidity ; COVID-19 - complications ; COVID-19 Testing ; Covid‐19 Special Forum ; Cross-Sectional Studies ; Dermatologic Agents - therapeutic use ; Female ; Humans ; Letter to the Editor ; Male ; Middle Aged ; Psoriasis - therapy ; SARS-CoV-2 ; Telemedicine</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2020-11, Vol.34 (11), p.e676-e679</ispartof><rights>2020 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5131-1b35923f3c7c1e7a57ceb51ca4f3d53d15c586f5d8c5c2849abd32a95fac05d33</citedby><cites>FETCH-LOGICAL-c5131-1b35923f3c7c1e7a57ceb51ca4f3d53d15c586f5d8c5c2849abd32a95fac05d33</cites><orcidid>0000-0002-5142-2479 ; 0000-0002-2850-867X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.16761$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.16761$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32564417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fougerousse, A.‐C.</creatorcontrib><creatorcontrib>Perrussel, M.</creatorcontrib><creatorcontrib>Bécherel, P.‐A.</creatorcontrib><creatorcontrib>Begon, E.</creatorcontrib><creatorcontrib>Pallure, V.</creatorcontrib><creatorcontrib>Zaraa, I.</creatorcontrib><creatorcontrib>Chaby, G.</creatorcontrib><creatorcontrib>Parier, J.</creatorcontrib><creatorcontrib>Kemula, M.</creatorcontrib><creatorcontrib>Mery‐Bossard, L.</creatorcontrib><creatorcontrib>Poreaux, C.</creatorcontrib><creatorcontrib>Taieb, C.</creatorcontrib><creatorcontrib>Maccari, F.</creatorcontrib><creatorcontrib>Reguiai, Z.</creatorcontrib><creatorcontrib>GEM Resopso</creatorcontrib><creatorcontrib>the GEM Resopso</creatorcontrib><title>Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Biological Products - therapeutic use</subject><subject>Comorbidity</subject><subject>COVID-19 - complications</subject><subject>COVID-19 Testing</subject><subject>Covid‐19 Special Forum</subject><subject>Cross-Sectional Studies</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Psoriasis - therapy</subject><subject>SARS-CoV-2</subject><subject>Telemedicine</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9O3DAQh60KVLa0h74A8hEOgYwd58-lEtotBYTEoS1Xy3EmYEjirSe71d54hD5jnwQvCwgO-GJr5tM3I_8Y-wrpIcRzdNssDyEvcvjAJpDlZSLTUm6xSVqJPKkqVe2wT0S3aZoCqPIj25FC5VkGxYQNP1c0Yu8s94HXznf-Or7HgGbscRi5G_icfHCGHPG5GV0sEm88Eh_8um0jSsjHG-TB0R33LTeccIkBeetDvy5ML6_OZv_v_0H1mW23piP88nTvst8n339NT5OLyx9n0-OLxCqQkEAtVSVkK21hAQujCou1AmuyVjZKNqCsKvNWNaVVVpRZZepGClOp1thUNVLusm8b73xR99jYuHUwnZ4H15uw0t44_bYzuBt97Ze6kEKCUlGw_yQI_s8CadS9I4tdZwb0C9Iiiz8pyjwXET3YoDZ4ooDtyxhI9TofHfPRj_lEdu_1Xi_kcyARONoAf12Hq_dN-nx2tVE-AKtbnN8</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Fougerousse, A.‐C.</creator><creator>Perrussel, M.</creator><creator>Bécherel, P.‐A.</creator><creator>Begon, E.</creator><creator>Pallure, V.</creator><creator>Zaraa, I.</creator><creator>Chaby, G.</creator><creator>Parier, J.</creator><creator>Kemula, M.</creator><creator>Mery‐Bossard, L.</creator><creator>Poreaux, C.</creator><creator>Taieb, C.</creator><creator>Maccari, F.</creator><creator>Reguiai, Z.</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5142-2479</orcidid><orcidid>https://orcid.org/0000-0002-2850-867X</orcidid></search><sort><creationdate>202011</creationdate><title>Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19</title><author>Fougerousse, A.‐C. ; Perrussel, M. ; Bécherel, P.‐A. ; Begon, E. ; Pallure, V. ; Zaraa, I. ; Chaby, G. ; Parier, J. ; Kemula, M. ; Mery‐Bossard, L. ; Poreaux, C. ; Taieb, C. ; Maccari, F. ; Reguiai, Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5131-1b35923f3c7c1e7a57ceb51ca4f3d53d15c586f5d8c5c2849abd32a95fac05d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological Products - therapeutic use</topic><topic>Comorbidity</topic><topic>COVID-19 - complications</topic><topic>COVID-19 Testing</topic><topic>Covid‐19 Special Forum</topic><topic>Cross-Sectional Studies</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Psoriasis - therapy</topic><topic>SARS-CoV-2</topic><topic>Telemedicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fougerousse, A.‐C.</creatorcontrib><creatorcontrib>Perrussel, M.</creatorcontrib><creatorcontrib>Bécherel, P.‐A.</creatorcontrib><creatorcontrib>Begon, E.</creatorcontrib><creatorcontrib>Pallure, V.</creatorcontrib><creatorcontrib>Zaraa, I.</creatorcontrib><creatorcontrib>Chaby, G.</creatorcontrib><creatorcontrib>Parier, J.</creatorcontrib><creatorcontrib>Kemula, M.</creatorcontrib><creatorcontrib>Mery‐Bossard, L.</creatorcontrib><creatorcontrib>Poreaux, C.</creatorcontrib><creatorcontrib>Taieb, C.</creatorcontrib><creatorcontrib>Maccari, F.</creatorcontrib><creatorcontrib>Reguiai, Z.</creatorcontrib><creatorcontrib>GEM Resopso</creatorcontrib><creatorcontrib>the GEM Resopso</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fougerousse, A.‐C.</au><au>Perrussel, M.</au><au>Bécherel, P.‐A.</au><au>Begon, E.</au><au>Pallure, V.</au><au>Zaraa, I.</au><au>Chaby, G.</au><au>Parier, J.</au><au>Kemula, M.</au><au>Mery‐Bossard, L.</au><au>Poreaux, C.</au><au>Taieb, C.</au><au>Maccari, F.</au><au>Reguiai, Z.</au><aucorp>GEM Resopso</aucorp><aucorp>the GEM Resopso</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>34</volume><issue>11</issue><spage>e676</spage><epage>e679</epage><pages>e676-e679</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>32564417</pmid><doi>10.1111/jdv.16761</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-5142-2479</orcidid><orcidid>https://orcid.org/0000-0002-2850-867X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2020-11, Vol.34 (11), p.e676-e679 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7323155 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Aged Biological Products - therapeutic use Comorbidity COVID-19 - complications COVID-19 Testing Covid‐19 Special Forum Cross-Sectional Studies Dermatologic Agents - therapeutic use Female Humans Letter to the Editor Male Middle Aged Psoriasis - therapy SARS-CoV-2 Telemedicine |
| title | Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A03%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20or%20biologic%20treatment%20in%20psoriasis%20patients%20does%20not%20increase%20the%20risk%20of%20a%20severe%20form%20of%20COVID%E2%80%9019&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Fougerousse,%20A.%E2%80%90C.&rft.aucorp=GEM%20Resopso&rft.date=2020-11&rft.volume=34&rft.issue=11&rft.spage=e676&rft.epage=e679&rft.pages=e676-e679&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.16761&rft_dat=%3Cproquest_pubme%3E2415828662%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2415828662&rft_id=info:pmid/32564417&rfr_iscdi=true |